BACKGROUND: Quantification of particle deposition in the lung by gamma scintigraphy requires a reference image for location of regions of interest (ROIs) and normalization to lung thickness. In various laboratories, the reference image is made by a transmission scan ((57)Co or (99m)Tc) or gas ventilation scan ((133)Xe or (81)Kr). There has not been a direct comparison of measures from the two methods. METHODS: We compared (99m)Tc transmission scans to (133)Xe equilibrium ventilation scans as reference images for 38 healthy subjects and 14 cystic fibrosis (CF) patients for their effects on measures of regional particle deposition: the central-to-peripheral ratio of lung counts (C/P); and ROI area versus forced vital capacity. Whole right lung ROI was based on either an isocontour threshold of three times the soft tissue transmission (TT) or a threshold of 20% of peak xenon ventilation counts (XV). We used a central ROI drawn to 50% of height and of width of the whole right lung ROI and placed along the left lung margin and centered vertically. RESULTS: In general, the correlation of normalized C/P (nC/P) between the two methods was strong. However, the value of nC/P was significantly smaller for the XV method than the TT method. Regression equations for the relationship of nC/P between the two methods were, for healthy subjects, y=0.75x+0.61, R(2)=0.64 using rectangular ROIs and y=0.76x+0.45, R(2)=0.66 using isocontour ROIs; and for CF patients, y=0.94x+0.46, R(2)=0.43 and y=0.85x+0.42, R(2)=0.41, respectively. CONCLUSIONS: (1) A transmission scan with an isocontour outline in combination with a rectangular central region to define the lung borders may be more useful than a ventilation scan. (2) Close correlation of nC/Ps measured by transmission or gas ventilation should allow confident comparison of values determined by the two methods.
BACKGROUND: Quantification of particle deposition in the lung by gamma scintigraphy requires a reference image for location of regions of interest (ROIs) and normalization to lung thickness. In various laboratories, the reference image is made by a transmission scan ((57)Co or (99m)Tc) or gas ventilation scan ((133)Xe or (81)Kr). There has not been a direct comparison of measures from the two methods. METHODS: We compared (99m)Tc transmission scans to (133)Xe equilibrium ventilation scans as reference images for 38 healthy subjects and 14 cystic fibrosis (CF) patients for their effects on measures of regional particle deposition: the central-to-peripheral ratio of lung counts (C/P); and ROI area versus forced vital capacity. Whole right lung ROI was based on either an isocontour threshold of three times the soft tissue transmission (TT) or a threshold of 20% of peak xenon ventilation counts (XV). We used a central ROI drawn to 50% of height and of width of the whole right lung ROI and placed along the left lung margin and centered vertically. RESULTS: In general, the correlation of normalized C/P (nC/P) between the two methods was strong. However, the value of nC/P was significantly smaller for the XV method than the TT method. Regression equations for the relationship of nC/P between the two methods were, for healthy subjects, y=0.75x+0.61, R(2)=0.64 using rectangular ROIs and y=0.76x+0.45, R(2)=0.66 using isocontour ROIs; and for CFpatients, y=0.94x+0.46, R(2)=0.43 and y=0.85x+0.42, R(2)=0.41, respectively. CONCLUSIONS: (1) A transmission scan with an isocontour outline in combination with a rectangular central region to define the lung borders may be more useful than a ventilation scan. (2) Close correlation of nC/Ps measured by transmission or gas ventilation should allow confident comparison of values determined by the two methods.
Authors: William D Bennett; Evangelia Daviskas; Amir Hasani; Jann Mortensen; John Fleming; Gerhard Scheuch Journal: J Aerosol Med Pulm Drug Deliv Date: 2010-10 Impact factor: 2.849
Authors: Martyn F Biddiscombe; Sally N Meah; S Richard Underwood; Omar S Usmani Journal: J Aerosol Med Pulm Drug Deliv Date: 2011-03-31 Impact factor: 2.849
Authors: Wayne H Anderson; Raymond D Coakley; Brian Button; Ashley G Henderson; Kirby L Zeman; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C William Davis; Summer Bailey; Fred Fuller; Martha Almond; Bahjat Qaqish; Elena Bordonali; Michael Rubinstein; William D Bennett; Mehmet Kesimer; Richard C Boucher Journal: Am J Respir Crit Care Med Date: 2015-07-15 Impact factor: 21.405
Authors: Kirby L Zeman; Juan Rojas Balcazar; Fred Fuller; Karl H Donn; Richard C Boucher; William D Bennett; Scott H Donaldson Journal: J Aerosol Med Pulm Drug Deliv Date: 2017-02-03 Impact factor: 2.849
Authors: Scott H Donaldson; Beth L Laube; Timothy E Corcoran; Pradeep Bhambhvani; Kirby Zeman; Agathe Ceppe; Pamela L Zeitlin; Peter J Mogayzel; Michael Boyle; Landon W Locke; Michael M Myerburg; Joseph M Pilewski; Brian Flanagan; Steven M Rowe; William D Bennett Journal: JCI Insight Date: 2018-12-20
Authors: William D Bennett; Miao Xie; Kirby Zeman; Harry Hurd; Scott Donaldson Journal: J Aerosol Med Pulm Drug Deliv Date: 2014-11-13 Impact factor: 2.849
Authors: Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas Journal: J Aerosol Med Pulm Drug Deliv Date: 2018-04-19 Impact factor: 2.849
Authors: William D Bennett; Kirby L Zeman; Beth L Laube; Jihong Wu; Gail Sharpless; Peter J Mogayzel; Scott H Donaldson Journal: J Aerosol Med Pulm Drug Deliv Date: 2017-10-16 Impact factor: 2.849
Authors: William D Bennett; Ashley G Henderson; Agathe Ceppe; Kirby L Zeman; Jihong Wu; Christine Gladman; Fred Fuller; Stephen Gazda; Brian Button; Richard C Boucher; Scott H Donaldson Journal: ERJ Open Res Date: 2020-08-11
Authors: W D Bennett; J Wu; F Fuller; J R Balcazar; K L Zeman; H Duckworth; K H Donn; T G O'Riordan; R C Boucher; S H Donaldson Journal: J Appl Physiol (1985) Date: 2015-04-24
Authors: Aaron T Trimble; A Whitney Brown; Beth L Laube; Noah Lechtzin; Kirby L Zeman; Jihong Wu; Agathe Ceppe; David Waltz; William D Bennett; Scott H Donaldson Journal: J Cyst Fibros Date: 2018-01-20 Impact factor: 5.482